Cargando…

Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community

BACKGROUND: Over 90% of antibiotics for human use in Europe are prescribed in primary care. We assessed the congruence between primary care treatment guidelines for skin infections and commensal Staphylococcus aureus (S. aureus) antimicrobial resistance levels in community-dwelling persons. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: van Bijnen, Evelien ME, Paget, W John, den Heijer, Casper DJ, Stobberingh, Ellen E, Bruggeman, Cathrien A, Schellevis, François G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220054/
https://www.ncbi.nlm.nih.gov/pubmed/25413920
http://dx.doi.org/10.1186/s12875-014-0175-8
_version_ 1782342685472849920
author van Bijnen, Evelien ME
Paget, W John
den Heijer, Casper DJ
Stobberingh, Ellen E
Bruggeman, Cathrien A
Schellevis, François G
author_facet van Bijnen, Evelien ME
Paget, W John
den Heijer, Casper DJ
Stobberingh, Ellen E
Bruggeman, Cathrien A
Schellevis, François G
author_sort van Bijnen, Evelien ME
collection PubMed
description BACKGROUND: Over 90% of antibiotics for human use in Europe are prescribed in primary care. We assessed the congruence between primary care treatment guidelines for skin infections and commensal Staphylococcus aureus (S. aureus) antimicrobial resistance levels in community-dwelling persons. METHODS: The prevalence of antimicrobial resistance in S. aureus was analysed by taking nose swabs from healthy primary care patients in nine European countries (total N = 32,032). Primary care treatment guidelines for bacterial skin infections were interpreted with respect to these antimicrobial resistance patterns. First- and second-choice recommendations were assessed and considered congruent if resistance to the antibiotic did not exceed 20%. RESULTS: We included primary care treatment guidelines for impetigo, cellulitis, folliculitis and furuncle. Treatment recommendations in all countries were consistent: most of the first-choice recommendations were beta-lactams, both for children and adults. Antimicrobial resistance levels were low, except for penicillin (on average 73% resistance). Considerable variation in antimicrobial resistance levels was found between countries, with Sweden displaying the lowest levels and Spain the highest. In some countries resistance to penicillin and azithromycin was significantly higher in children (4-17 years) compared with adults. CONCLUSIONS: Most of the first- and second-choice recommendations in the treatment guidelines for skin infections were congruent with commensal S. aureus antimicrobial resistance patterns in the community, except for two recommendations for penicillin. Given the variation in antimicrobial resistance levels between countries, age groups and health care settings, national data regarding antimicrobial resistance in the community should be taken into account when updating or developing primary care treatment guidelines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12875-014-0175-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4220054
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42200542014-11-06 Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community van Bijnen, Evelien ME Paget, W John den Heijer, Casper DJ Stobberingh, Ellen E Bruggeman, Cathrien A Schellevis, François G BMC Fam Pract Research Article BACKGROUND: Over 90% of antibiotics for human use in Europe are prescribed in primary care. We assessed the congruence between primary care treatment guidelines for skin infections and commensal Staphylococcus aureus (S. aureus) antimicrobial resistance levels in community-dwelling persons. METHODS: The prevalence of antimicrobial resistance in S. aureus was analysed by taking nose swabs from healthy primary care patients in nine European countries (total N = 32,032). Primary care treatment guidelines for bacterial skin infections were interpreted with respect to these antimicrobial resistance patterns. First- and second-choice recommendations were assessed and considered congruent if resistance to the antibiotic did not exceed 20%. RESULTS: We included primary care treatment guidelines for impetigo, cellulitis, folliculitis and furuncle. Treatment recommendations in all countries were consistent: most of the first-choice recommendations were beta-lactams, both for children and adults. Antimicrobial resistance levels were low, except for penicillin (on average 73% resistance). Considerable variation in antimicrobial resistance levels was found between countries, with Sweden displaying the lowest levels and Spain the highest. In some countries resistance to penicillin and azithromycin was significantly higher in children (4-17 years) compared with adults. CONCLUSIONS: Most of the first- and second-choice recommendations in the treatment guidelines for skin infections were congruent with commensal S. aureus antimicrobial resistance patterns in the community, except for two recommendations for penicillin. Given the variation in antimicrobial resistance levels between countries, age groups and health care settings, national data regarding antimicrobial resistance in the community should be taken into account when updating or developing primary care treatment guidelines. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12875-014-0175-8) contains supplementary material, which is available to authorized users. BioMed Central 2014-10-25 /pmc/articles/PMC4220054/ /pubmed/25413920 http://dx.doi.org/10.1186/s12875-014-0175-8 Text en © van Bijnen et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
van Bijnen, Evelien ME
Paget, W John
den Heijer, Casper DJ
Stobberingh, Ellen E
Bruggeman, Cathrien A
Schellevis, François G
Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community
title Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community
title_full Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community
title_fullStr Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community
title_full_unstemmed Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community
title_short Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community
title_sort primary care treatment guidelines for skin infections in europe: congruence with antimicrobial resistance found in commensal staphylococcus aureus in the community
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220054/
https://www.ncbi.nlm.nih.gov/pubmed/25413920
http://dx.doi.org/10.1186/s12875-014-0175-8
work_keys_str_mv AT vanbijnenevelienme primarycaretreatmentguidelinesforskininfectionsineuropecongruencewithantimicrobialresistancefoundincommensalstaphylococcusaureusinthecommunity
AT pagetwjohn primarycaretreatmentguidelinesforskininfectionsineuropecongruencewithantimicrobialresistancefoundincommensalstaphylococcusaureusinthecommunity
AT denheijercasperdj primarycaretreatmentguidelinesforskininfectionsineuropecongruencewithantimicrobialresistancefoundincommensalstaphylococcusaureusinthecommunity
AT stobberinghellene primarycaretreatmentguidelinesforskininfectionsineuropecongruencewithantimicrobialresistancefoundincommensalstaphylococcusaureusinthecommunity
AT bruggemancathriena primarycaretreatmentguidelinesforskininfectionsineuropecongruencewithantimicrobialresistancefoundincommensalstaphylococcusaureusinthecommunity
AT schellevisfrancoisg primarycaretreatmentguidelinesforskininfectionsineuropecongruencewithantimicrobialresistancefoundincommensalstaphylococcusaureusinthecommunity
AT primarycaretreatmentguidelinesforskininfectionsineuropecongruencewithantimicrobialresistancefoundincommensalstaphylococcusaureusinthecommunity